Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Discovery & Development

Discovery & Development Drug Discovery

World TB Day: Understanding the Roadblocks to Progress

| Maryam Mahdi

It's time to take action against TB.

Discovery & Development Advanced Medicine

Perusing the Pipeline

| James Strachan

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.

Discovery & Development Analytical Science

The Color of Chirality

| Maryam Mahdi

Forty years ago, it was theorized that chirality had a color composition that could be measured… and finally the theory has been proven.

Discovery & Development Analytical Science

At the Cutting-Edge of Pharma Analytics

Meet the analytical experts working at the cutting-edge of pharma analytics to ensure the safety of medicines.

Discovery & Development Clinical Trials

With Age Comes Challenges But Not Trials

| Maryam Mahdi, Stephanie Sutton

A key focus of Andrew McLachlan’s career is understanding the impact of aging on drug disposition and response to medicines.

Discovery & Development Drug Delivery

The Elderly Are the Future

| Erin O’Brien, Chris Evans

Drug delivery devices must take into account the needs of older adults.

Discovery & Development Formulation

In Conversation with Dr. Martin Klatt of BASF

| Sponsored by BASF

The Medicine Maker speaks with Dr. Martin Klatt, Director Sales Pharma Solutions Europe from BASF

Discovery & Development Formulation

Taste the Rainbow

| Nicolas Madit

The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.

Discovery & Development Small Molecules

Solutions in... Drug Development

| James Strachan

Douglas J. Swirsky, CEO of Rexahn Pharmaceuticals, explains his company’s approach to developing more effective cancer treatments.

Discovery & Development Formulation

In Conversation with Jeanne Thoma of SPI Pharma

| James Strachan

The Medicine Maker speaks with Jeanne Thoma, President and CEO from SPI Pharma

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register